Added to YB: 2025-04-23
Pitch date: 2025-04-20
1681.HK [neutral]
Consun Pharmaceutical Group Limited
+81.71%
current return
Author Info
Momentum Financial researches stocks from around the world to invest in for the long-term. Sign up for the newsletter.
Company Info
Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China.
Market Cap
HKD 10.8B
Pitch Price
HKD 8.47
Price Target
N/A
Dividend
5.29%
EV/EBITDA
5.36
P/E
9.34
EV/Sales
2.02
Sector
Pharmaceuticals
Category
growth
Consun Pharma News
1681.HK (update): Secondary listing of Consun Pharma catching investor attention - Fidelity & GL Capital both >5% holders. TCM firm expanding via Macao partnership for int'l markets & TCMG USA deal. New Roxadustat generic entering 5B yuan kidney market, leveraging existing 2B yuan Niaoduqing presence in 90% of tertiary hospitals. 3-way battle with AstraZeneca & CSPC.
Read full article (7 min)